DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control

INTRODUCTION: This study aims to compare the risks of cancer among patients with type 2 diabetes mellitus (T2DM) on metformin–sulfonylurea dual therapy intensified with dipeptidyl peptidase 4 inhibitors (DPP4i), thiazolidinediones, or insulin. RESEARCH DESIGN AND METHODS: We assembled a retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Carlos K H, Man, Kenneth K C, Chan, Esther W Y, Wu, Tingting, Tse, Emily T Y, Wong, Ian C K, Lam, Cindy L K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295418/
https://www.ncbi.nlm.nih.gov/pubmed/32532851
http://dx.doi.org/10.1136/bmjdrc-2020-001346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295418/
https://www.ncbi.nlm.nih.gov/pubmed/32532851
http://dx.doi.org/10.1136/bmjdrc-2020-001346

Ejemplares similares